Cargando…

Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B

During the continued isolation of different bacteria from highly diverse, low human activity environments in Ghana and the subsequent characterization and biological activity studies of their secondary metabolites, we found both Gram-positive and Gram-negative Bacillus strains to be ubiquitous and w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nartey, Adwoa P, Dofuor, Aboagye K, Owusu, Kofi B A, Camas, Anil S, Deng, Hai, Jaspars, Marcel, Kyeremeh, Kwaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811306/
https://www.ncbi.nlm.nih.gov/pubmed/36632531
http://dx.doi.org/10.3762/bjoc.18.185
_version_ 1784863505086676992
author Nartey, Adwoa P
Dofuor, Aboagye K
Owusu, Kofi B A
Camas, Anil S
Deng, Hai
Jaspars, Marcel
Kyeremeh, Kwaku
author_facet Nartey, Adwoa P
Dofuor, Aboagye K
Owusu, Kofi B A
Camas, Anil S
Deng, Hai
Jaspars, Marcel
Kyeremeh, Kwaku
author_sort Nartey, Adwoa P
collection PubMed
description During the continued isolation of different bacteria from highly diverse, low human activity environments in Ghana and the subsequent characterization and biological activity studies of their secondary metabolites, we found both Gram-positive and Gram-negative Bacillus strains to be ubiquitous and widespread. One of such strains, the Ghanaian novel Bacillus sp. strain DE2B was isolated from rhizosphere soils collected from the Digya National Park in Ghana. Chromatographic purifications of the fermented culture extract of the strain DE2B, led to the isolation of a cyclic lipopeptide, digyalipopeptide A (1). Using 1D and 2D NMR data, mass spectrometry sequence tagging, advanced Marfey’s analysis, and the GNPS molecular networking we solved the full structure of digyalipopeptide A (1). We found that compound 1 is a member of a somewhat homologous series of peptides produced as a mixture by the strain containing the same amino acid sequence in the cyclic peptide backbone but differing only by the length of aliphatic fatty acid side chains. When tested against Trypanosoma brucei subsp. brucei strain GUTat 3.1 and Leishmania donovani (Laveran and Mesnil) Ross (D10), digyalipopeptide A (1) gave IC(50) values of 12.89 µM (suramin IC(50) 0.96 µM) and 4.85 µM (amphotericin B IC(50) 4.87 µM), respectively. Furthermore, digyalipopeptide A (1) produced IC(50) values of 10.07 µM (ampicillin IC(50) 0.18 µM) and 10.01 µM (ampicillin IC(50) 1.53 µM) for Staphylococcus aureus and Shigella sonnei, respectively. The selectivity and toxicity profile of compound 1 was investigated using normal cell lines, macrophages RAW 264.7. When tested against normal macrophages, compound 1 gave an IC(50) value of 71.32 μM. Selectivity indices (SI) were obtained by calculating the ratio of the IC(50) in RAW 264.7 to the IC(50) in the respective microbe and neglected parasite. In the presence of RAW 264.7 cell lines, compound 1 was particularly selective towards Leishmania donovani (Laveran and Mesnil) Ross (D10) with an SI value of 14.71. The bioactivity studies conducted confirm the role of these cyclic lipopeptides as defense chemicals in their natural environment and their ability to be biologically active across different species.
format Online
Article
Text
id pubmed-9811306
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-98113062023-01-10 Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B Nartey, Adwoa P Dofuor, Aboagye K Owusu, Kofi B A Camas, Anil S Deng, Hai Jaspars, Marcel Kyeremeh, Kwaku Beilstein J Org Chem Full Research Paper During the continued isolation of different bacteria from highly diverse, low human activity environments in Ghana and the subsequent characterization and biological activity studies of their secondary metabolites, we found both Gram-positive and Gram-negative Bacillus strains to be ubiquitous and widespread. One of such strains, the Ghanaian novel Bacillus sp. strain DE2B was isolated from rhizosphere soils collected from the Digya National Park in Ghana. Chromatographic purifications of the fermented culture extract of the strain DE2B, led to the isolation of a cyclic lipopeptide, digyalipopeptide A (1). Using 1D and 2D NMR data, mass spectrometry sequence tagging, advanced Marfey’s analysis, and the GNPS molecular networking we solved the full structure of digyalipopeptide A (1). We found that compound 1 is a member of a somewhat homologous series of peptides produced as a mixture by the strain containing the same amino acid sequence in the cyclic peptide backbone but differing only by the length of aliphatic fatty acid side chains. When tested against Trypanosoma brucei subsp. brucei strain GUTat 3.1 and Leishmania donovani (Laveran and Mesnil) Ross (D10), digyalipopeptide A (1) gave IC(50) values of 12.89 µM (suramin IC(50) 0.96 µM) and 4.85 µM (amphotericin B IC(50) 4.87 µM), respectively. Furthermore, digyalipopeptide A (1) produced IC(50) values of 10.07 µM (ampicillin IC(50) 0.18 µM) and 10.01 µM (ampicillin IC(50) 1.53 µM) for Staphylococcus aureus and Shigella sonnei, respectively. The selectivity and toxicity profile of compound 1 was investigated using normal cell lines, macrophages RAW 264.7. When tested against normal macrophages, compound 1 gave an IC(50) value of 71.32 μM. Selectivity indices (SI) were obtained by calculating the ratio of the IC(50) in RAW 264.7 to the IC(50) in the respective microbe and neglected parasite. In the presence of RAW 264.7 cell lines, compound 1 was particularly selective towards Leishmania donovani (Laveran and Mesnil) Ross (D10) with an SI value of 14.71. The bioactivity studies conducted confirm the role of these cyclic lipopeptides as defense chemicals in their natural environment and their ability to be biologically active across different species. Beilstein-Institut 2022-12-28 /pmc/articles/PMC9811306/ /pubmed/36632531 http://dx.doi.org/10.3762/bjoc.18.185 Text en Copyright © 2022, Nartey et al. https://creativecommons.org/licenses/by/4.0/This is an open access article licensed under the terms of the Beilstein-Institut Open Access License Agreement (https://www.beilstein-journals.org/bjoc/terms/terms), which is identical to the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ). The reuse of material under this license requires that the author(s), source and license are credited. Third-party material in this article could be subject to other licenses (typically indicated in the credit line), and in this case, users are required to obtain permission from the license holder to reuse the material.
spellingShingle Full Research Paper
Nartey, Adwoa P
Dofuor, Aboagye K
Owusu, Kofi B A
Camas, Anil S
Deng, Hai
Jaspars, Marcel
Kyeremeh, Kwaku
Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B
title Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B
title_full Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B
title_fullStr Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B
title_full_unstemmed Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B
title_short Digyalipopeptide A, an antiparasitic cyclic peptide from the Ghanaian Bacillus sp. strain DE2B
title_sort digyalipopeptide a, an antiparasitic cyclic peptide from the ghanaian bacillus sp. strain de2b
topic Full Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811306/
https://www.ncbi.nlm.nih.gov/pubmed/36632531
http://dx.doi.org/10.3762/bjoc.18.185
work_keys_str_mv AT narteyadwoap digyalipopeptideaanantiparasiticcyclicpeptidefromtheghanaianbacillusspstrainde2b
AT dofuoraboagyek digyalipopeptideaanantiparasiticcyclicpeptidefromtheghanaianbacillusspstrainde2b
AT owusukofiba digyalipopeptideaanantiparasiticcyclicpeptidefromtheghanaianbacillusspstrainde2b
AT camasanils digyalipopeptideaanantiparasiticcyclicpeptidefromtheghanaianbacillusspstrainde2b
AT denghai digyalipopeptideaanantiparasiticcyclicpeptidefromtheghanaianbacillusspstrainde2b
AT jasparsmarcel digyalipopeptideaanantiparasiticcyclicpeptidefromtheghanaianbacillusspstrainde2b
AT kyeremehkwaku digyalipopeptideaanantiparasiticcyclicpeptidefromtheghanaianbacillusspstrainde2b